Dennis Leung received his PhD in Chemistry from the University of California, Berkeley in 2006 working on supramolecular chemistry as a joint student with Prof. Bob Bergman and Ken Raymond. He then pursued a postdoctoral position at the University of California, Irvine working on designing novel polymerization catalysts before beginning his industrial career at Merck in the Pharmaceutical Sciences department. He moved to Genentech in early 2016 where he is currently a Director and Principal Scientific Manager of the Discovery Pharmaceutics and Preformulation group within the Genentech Research and Early Development organization. This is a new interdisciplinary group that supports new drug candidates in the drug discovery and early drug development phases with a focus on pharmaceutics, materials science, formulation, and drug delivery.
Dennis Leung received his PhD in Chemistry from the University of California, Berkeley in 2006 working on supramolecular chemistry as a joint student with Prof. Bob Bergman and Ken Raymond. He then pursued a postdoctoral position at the University of California, Irvine working on designing novel polymerization catalysts before beginning his industrial career at Merck in the Pharmaceutical Sciences department. He moved to Genentech in early 2016 where he is currently a Director and Principal Scientific Manager of the Discovery Pharmaceutics and Preformulation group within the Genentech Research and Early Development organization. This is a new interdisciplinary group that supports new drug candidates in the drug discovery and early drug development phases with a focus on pharmaceutics, materials science, formulation, and drug delivery.